NASDAQ:MGTX MeiraGTx (MGTX) Stock Price, News & Analysis $5.06 -0.03 (-0.59%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$4.96▼$5.2450-Day Range$3.94▼$5.6652-Week Range$3.49▼$7.60Volume123,545 shsAverage Volume165,681 shsMarket Capitalization$325.41 millionP/E RatioN/ADividend YieldN/APrice Target$26.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get MeiraGTx alerts: Email Address MeiraGTx MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside413.8% Upside$26.00 Price TargetShort InterestBearish2.44% of Shares Sold ShortDividend StrengthN/ASustainability-0.54Upright™ Environmental ScoreNews Sentiment0.94Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.52) to $0.87 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.33 out of 5 starsMedical Sector164th out of 936 stocksBiological Products, Except Diagnostic Industry17th out of 154 stocks 3.5 Analyst's Opinion Consensus RatingMeiraGTx has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageMeiraGTx has received no research coverage in the past 90 days.Read more about MeiraGTx's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted2.44% of the outstanding shares of MeiraGTx have been sold short.Short Interest Ratio / Days to CoverMeiraGTx has a short interest ratio ("days to cover") of 8.9.Change versus previous monthShort interest in MeiraGTx has recently increased by 8.28%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldMeiraGTx does not currently pay a dividend.Dividend GrowthMeiraGTx does not have a long track record of dividend growth. Previous Next 4.8 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreMeiraGTx has received a 78.28% net impact score from Upright. The largest positive contribution comes from its "Creating knowledge" impact, which is false driven by its "Preclinical research services for physical health", "Clinical research services for physiological diseases ", and "Basic medical research services" products. See details.Environmental SustainabilityThe Environmental Impact score for MeiraGTx is -0.54. Previous Next 3.9 News and Social Media Coverage News SentimentMeiraGTx has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for MeiraGTx this week, compared to 1 article on an average week.Search Interest2 people have searched for MGTX on MarketBeat in the last 30 days. MarketBeat Follows3 people have added MeiraGTx to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, MeiraGTx insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 8.40% of the stock of MeiraGTx is held by insiders.Percentage Held by Institutions67.48% of the stock of MeiraGTx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about MeiraGTx's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for MeiraGTx are expected to grow in the coming year, from ($1.52) to $0.87 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of MeiraGTx is -4.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of MeiraGTx is -4.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMeiraGTx has a P/B Ratio of 2.33. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about MeiraGTx's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here About MeiraGTx Stock (NASDAQ:MGTX)MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia. Its programs in clinical development include Phase I/II clinical stage programs in achromatopsia, X-linked retinitis pigmentosa, and RPE65-deficiency; Phase I clinical trials for radiation-induced xerostomia; and Parkinson's program that has completed a Phase II trial. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease. The company was incorporated in 2015 and is based in New York, New York.Read More MGTX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MGTX Stock News HeadlinesJuly 27 at 1:14 AM | americanbankingnews.comHead to Head Survey: Ocugen (NASDAQ:OCGN) and MeiraGTx (NASDAQ:MGTX)July 22, 2024 | uk.finance.yahoo.comMeiraGTx Holdings PLC (328.MU)July 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.May 13, 2024 | finance.yahoo.comAnalyst Forecasts For MeiraGTx Holdings plc (NASDAQ:MGTX) Are Surging HigherMay 10, 2024 | finance.yahoo.comMeiraGTx Holdings PLC Reports First Quarter 2024 Financial ResultsMay 10, 2024 | finance.yahoo.comMeiraGTx Holdings First Quarter 2024 Earnings: US$0.32 loss per share (vs US$0.62 loss in 1Q 2023)May 9, 2024 | investing.comMeiraGTx (MGTX) Earnings Dates & ReportsMay 9, 2024 | investorplace.comMGTX Stock Earnings: MeiraGTx Hldgs Beats EPS, Misses Revenue for Q1 2024July 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.May 9, 2024 | globenewswire.comMeiraGTx Reports First Quarter 2024 Financial and Operational ResultsApril 25, 2024 | finance.yahoo.comMeiraGTx Holdings plc (NASDAQ:MGTX): Is Breakeven Near?April 24, 2024 | globenewswire.comMeiraGTx to Participate in Upcoming Investor ConferencesApril 18, 2024 | globenewswire.comMeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual ConferenceMarch 17, 2024 | finance.yahoo.comMGTX Apr 2024 12.500 callMarch 15, 2024 | markets.businessinsider.comBuy Rating Affirmed: Meiragtx Holdings’ Promising Pipeline and Strategic Partnerships Set Stage for GrowthMarch 14, 2024 | investorplace.comMGTX Stock Earnings: MeiraGTx Hldgs Beats EPS, Misses Revenue for Q4 2023March 14, 2024 | benzinga.comRecap: MeiraGTx Hldgs Q4 EarningsMarch 14, 2024 | hk.finance.yahoo.comMeiraGTx Holdings PLC Reports Notable Clinical Progress Amidst Financial Challenges in 2023See More Headlines Receive MGTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MeiraGTx and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today7/27/2024Next Earnings (Estimated)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:MGTX CUSIPN/A CIK1735438 Webwww.meiragtx.com Phone(646) 860-7985FaxN/AEmployees300Year FoundedN/APrice Target and Rating Average Stock Price Target$26.00 High Stock Price Target$41.00 Low Stock Price Target$11.00 Potential Upside/Downside+413.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($1.17) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-84,030,000.00 Net Margins-651.19% Pretax Margin-651.19% Return on Equity-122.82% Return on Assets-48.11% Debt Debt-to-Equity Ratio0.69 Current Ratio3.14 Quick Ratio3.14 Sales & Book Value Annual Sales$14.02 million Price / Sales23.21 Cash FlowN/A Price / Cash FlowN/A Book Value$2.17 per share Price / Book2.33Miscellaneous Outstanding Shares64,310,000Free Float58,905,000Market Cap$325.41 million OptionableOptionable Beta1.34 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesDr. Alexandria Forbes Ph.D. (Age 59)CEO, President & Director Comp: $2.89MMr. Richard Brian Giroux B.A. (Age 51)COO & CFO Comp: $2.14MDr. Stuart Naylor Ph.D. (Age 61)Chief Development Officer Comp: $1.06MMr. Robert J. Wollin J.D. (Age 48)General Counsel & Secretary Dr. Michel Michaelides M.D.Head of Clinical OphthalmologyMs. Christine Elise Sheehy (Age 56)Senior Vice President of Global Integration Mr. Tim RandallSenior Vice President of Risk & Internal ControlsDr. Alastair Leighton Ph.D.Senior Vice President of Manufacturing & Supply ChainDr. Robert K. Zeldin M.D. (Age 61)Chief Medical Officer Comp: $1.1MMore ExecutivesKey CompetitorsCellular Biomedicine GroupNASDAQ:CBMGHarpoon TherapeuticsNASDAQ:HARPFreeline TherapeuticsNASDAQ:FRLNCullinan TherapeuticsNASDAQ:CGEMAutolus TherapeuticsNASDAQ:AUTLView All CompetitorsInstitutional OwnershipBank of New York Mellon CorpSold 14,485 shares on 7/26/2024Ownership: 0.181%Hobbs Group Advisors LLCBought 38,932 shares on 7/22/2024Ownership: 0.061%Kennedy Capital Management LLCBought 16,457 shares on 5/16/2024Ownership: 0.026%CreativeOne Wealth LLCSold 5,119 shares on 5/14/2024Ownership: 0.112%EntryPoint Capital LLCBought 32,893 shares on 5/14/2024Ownership: 0.051%View All Institutional Transactions MGTX Stock Analysis - Frequently Asked Questions How have MGTX shares performed this year? MeiraGTx's stock was trading at $7.02 at the start of the year. Since then, MGTX stock has decreased by 27.9% and is now trading at $5.06. View the best growth stocks for 2024 here. How were MeiraGTx's earnings last quarter? MeiraGTx Holdings plc (NASDAQ:MGTX) issued its quarterly earnings data on Thursday, May, 9th. The company reported ($0.77) earnings per share for the quarter, missing analysts' consensus estimates of ($0.32) by $0.45. The business had revenue of $0.70 million for the quarter, compared to analysts' expectations of $16.38 million. MeiraGTx had a negative trailing twelve-month return on equity of 122.82% and a negative net margin of 651.19%. When did MeiraGTx IPO? MeiraGTx (MGTX) raised $75 million in an initial public offering on Friday, June 8th 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch, Barclays and Evercore ISI acted as the underwriters for the IPO and Chardan was co-manager. Who are MeiraGTx's major shareholders? Top institutional investors of MeiraGTx include Bank of New York Mellon Corp (0.18%) and Hobbs Group Advisors LLC (0.06%). Insiders that own company stock include Perceptive Advisors Llc, Robert K Zeldin, Robert J Wollin, Richard Giroux, Alexandria Forbes and Stuart Naylor. View institutional ownership trends. How do I buy shares of MeiraGTx? Shares of MGTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of MeiraGTx own? Based on aggregate information from My MarketBeat watchlists, some other companies that MeiraGTx investors own include AbbVie (ABBV), Sorrento Therapeutics (SRNE), Aldeyra Therapeutics (ALDX), Inovio Pharmaceuticals (INO), Kadmon (KDMN), Pfizer (PFE) and VBI Vaccines (VBIV). This page (NASDAQ:MGTX) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MeiraGTx Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share MeiraGTx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
